These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36270793)

  • 41. Dissociable Contributions of Thalamic-Subregions to Cognitive Impairment in Small Vessel Disease.
    Li H; Cai M; Jacob MA; Norris DG; Marques JP; Chamberland M; Duering M; Kessels RPC; de Leeuw FE; Tuladhar AM
    Stroke; 2023 May; 54(5):1367-1376. PubMed ID: 36912138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-6, PF-4, sCD40 L, and homocysteine are associated with the radiological progression of cerebral small-vessel disease: a 2-year follow-up study.
    Staszewski J; Piusińska-Macoch R; Brodacki B; Skrobowska E; Stępień A
    Clin Interv Aging; 2018; 13():1135-1141. PubMed ID: 29950823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
    Du H; Wilson D; Ambler G; Banerjee G; Shakeshaft C; Cohen H; Yousry T; Al-Shahi Salman R; Lip GYH; Houlden H; Brown MM; Muir KW; Jäger HR; Werring DJ;
    Stroke; 2021 Jan; 52(1):91-99. PubMed ID: 33280548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal changes in rich club organization and cognition in cerebral small vessel disease.
    van Leijsen EMC; van Uden IWM; Bergkamp MI; van der Holst HM; Norris DG; Claassen JAHR; Kessels RPC; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2019; 24():102048. PubMed ID: 31706220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late-onset depressive symptoms increase the risk of dementia in small vessel disease.
    van Uden IW; van der Holst HM; van Leijsen EM; Tuladhar AM; van Norden AG; de Laat KF; Claassen JA; van Dijk EJ; Kessels RP; Richard E; Tendolkar I; de Leeuw FE
    Neurology; 2016 Sep; 87(11):1102-9. PubMed ID: 27521430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fate of diffusion restricted lesions in acute intracerebral hemorrhage.
    Tsai YH; Lee MH; Weng HH; Chang SW; Yang JT; Huang YC
    PLoS One; 2014; 9(8):e105970. PubMed ID: 25166754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune regulation and blood-brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study - a multicentre prospective cohort study.
    Low A; van Winden S; Cai L; Kessels RPC; Maas MC; Morris RG; Nus M; Tozer DJ; Tuladhar A; van der Kolk A; Wolters R; Mallat Z; Riksen NP; Markus H; de Leeuw FE
    BMJ Open; 2024 Feb; 14(2):e084303. PubMed ID: 38413153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.
    Arba F; Quinn T; Hankey GJ; Ali M; Lees KR; Inzitari D;
    Eur J Neurol; 2017 Feb; 24(2):276-282. PubMed ID: 27862654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of small vessel disease and incidental DWI-positive lesions in patients with aneurysmal subarachnoid hemorrhage versus intracerebral hemorrhage.
    Wang ZJ; Hu X; Xie YF; Yao WJ; Deng L; Li ZQ; Pu MJ; Lv XN; Hu ZC; Zhang JT; Li Q
    Eur Stroke J; 2024 Feb; ():23969873241232327. PubMed ID: 38372251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism.
    Jacob MA; Cai M; Bergkamp M; Darweesh SKL; Gelissen LMY; Marques J; Norris DG; Duering M; Esselink RAJ; Tuladhar AM; de Leeuw FE
    Ann Neurol; 2023 Jun; 93(6):1130-1141. PubMed ID: 36762437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring causal pathways linking cerebral small vessel diseases burden to poststroke depressive symptoms with structural equation model analysis.
    Liang Y; Chen YK; Liu YL; Mok VCT; Ungvari GS; Chu WCW; Tang WK; Kim JS; Kim JM
    J Affect Disord; 2019 Jun; 253():218-223. PubMed ID: 31054447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study.
    Lawrence AJ; Patel B; Morris RG; MacKinnon AD; Rich PM; Barrick TR; Markus HS
    PLoS One; 2013; 8(4):e61014. PubMed ID: 23613774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease.
    Egle M; Hilal S; Tuladhar AM; Pirpamer L; Bell S; Hofer E; Duering M; Wason J; Morris RG; Dichgans M; Schmidt R; Tozer DJ; Barrick TR; Chen C; de Leeuw FE; Markus HS
    Neuroimage Clin; 2022; 35():103114. PubMed ID: 35908307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion-Weighted Lesions After Intracerebral Hemorrhage: Associated MRI Findings.
    Wiegertjes K; Voigt S; Jolink WMT; Koemans EA; Schreuder FHBM; van Walderveen MAA; Wermer MJH; Meijer FJA; Duering M; de Leeuw FE; Klijn CJM
    Front Neurol; 2022; 13():882070. PubMed ID: 35785361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural Network Efficiency Predicts Conversion to Incident Parkinsonism in Patients With Cerebral Small Vessel Disease.
    Cai M; Jacob MA; Marques J; Norris DG; Duering M; Esselink RAJ; Zhang Y; de Leeuw FE; Tuladhar AM
    J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37527837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease.
    Du J; Wang Y; Zhi N; Geng J; Cao W; Yu L; Mi J; Zhou Y; Xu Q; Wen W; Sachdev P
    Neuroimage Clin; 2019; 22():101712. PubMed ID: 30772684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between hemostatic markers, serum lipid fractions and progression of cerebral small vessel disease: A 2-year follow-up study.
    Staszewski J; Piusińska-Macoch R; Brodacki B; Skrobowska E; Stępień A
    Neurol Neurochir Pol; 2018; 52(1):54-63. PubMed ID: 29173807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
    Moonen JEF; Haan R; Bos I; Teunissen C; van de Giessen E; Tomassen J; den Braber A; van der Landen SM; de Geus EJC; Legdeur N; van Harten AC; Trieu C; de Boer C; Kroeze L; Barkhof F; Visser PJ; van der Flier WM
    Alzheimers Dement; 2024 Mar; 20(3):1868-1880. PubMed ID: 38146222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidental DWI Lesions in Patients with Recent Small Subcortical Infarctions.
    Arsava EM; Yilmaz E; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106304. PubMed ID: 35065404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial.
    Arba F; Mair G; Carpenter T; Sakka E; Sandercock PAG; Lindley RI; Inzitari D; Wardlaw JM;
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1506-1513. PubMed ID: 28314624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.